
Injective (INJ) jumps 27% after two US ETFs plan to hold and stake the token
Injective (INJ) surged 27.43% to $9.269 following announcements that two proposed U.S. ETFs plan to hold and stake the token. The 21Shares Injective ETF may stake part of its holdings if it poses no legal risk, while the Canary Staked INJ ETF intends...





